Fig. 2From: Blood eosinophils as a biomarker of future COPD exacerbation risk: pooled data from 11 clinical trialsa Eosinophil count at baseline by exacerbation history. b Eosinophil count at baseline by ICS use. ICS, inhaled corticosteroidsBack to article page